NCT06986941

Brief Summary

This study investigates the impact of an 8-week ballet-based dance therapy on people with Parkinson's disease. It aims to assess the effect of ballet on motor and non-motor symptoms, such as balance, cognitive function, functional capacity, and quality of life. The study will provide insights into the potential of ballet therapy as an effective, non-pharmacological treatment for Parkinson's disease.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Jun 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jun 2025Feb 2027

First Submitted

Initial submission to the registry

May 4, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

1.5 years

First QC Date

May 4, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

Ballet-based Dance TherapyRespiratory FunctionBalanceCognitive FunctionQuality of Life

Outcome Measures

Primary Outcomes (6)

  • Functional Capacity

    Functional capacity will be assessed using the Six-Minute Walk Test (6MWT) according to American Thoracic Society (ATS) guidelines. The total distance walked will be recorded.

    At baseline and at week 9 (after 8 weeks of intervention)

  • Forced Expiratory Volume in 1 Second (FEV₁)

    FEV₁ will be assessed using spirometry and reported in liters (L). FEV1 will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).

    At baseline and at week 9 (after 8 weeks of intervention)

  • Forced Vital Capacity (FVC)

    FVC will be assessed using spirometry and reported in liters (L). FVC will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).

    At baseline and at week 9 (after 8 weeks of intervention)

  • Tiffeneau Index (FEV₁/FVC Ratio)

    The ratio of FEV₁ to FVC will be calculated using spirometry and reported as a percentage (%).

    At baseline and at week 9 (after 8 weeks of intervention)

  • Peak Expiratory Flow (PEF)

    PEF will be assessed using spirometry and reported in liters per minute (L/min). PEF will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).

    At baseline and at week 9 (after 8 weeks of intervention)

  • Forced Expiratory Flow 25-75% (FEF₂₅-₇₅%)

    FEF₂₅-₇₅% will be assessed using spirometry and reported in liters per second (L/s). FEF₂₅-₇₅%will be measured according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).

    At baseline and at week 9 (after 8 weeks of intervention)

Secondary Outcomes (5)

  • Respiratory Muscle Strength

    At baseline and at week 9 (after 8 weeks of intervention)

  • Balance

    At baseline and at week 9 (after 8 weeks of intervention)

  • Cognitive Function

    At baseline and at week 9 (after 8 weeks of intervention)

  • Peripheral Muscle Strength

    At baseline and at week 9 (after 8 weeks of intervention)

  • Change in Quality of Life

    At baseline and at week 9 (after 8 weeks of intervention)

Study Arms (2)

Ballet-Based Dance Therapy

EXPERIMENTAL

Participants in this arm will engage in an 8-week ballet-based dance therapy program, specifically designed to enhance functional capacity, balance, peripheral muscle strength, cognitive function, and overall quality of life. The program will be conducted twice a week, with each session lasting approximately 60 minutes. The dance exercises will be tailored to meet the needs of individuals with Parkinson's disease, focusing on improving motor skills, flexibility, and coordination. The primary goal is to assess the impact of ballet-based exercises on various parameters such as respiratory function, balance, and muscle strength.

Behavioral: Ballet-Based Dance Therapy

Standard Care with Exercise Counseling

ACTIVE COMPARATOR

Participants in this arm will continue with their standard medical treatment for Parkinson's disease, including pharmacological management and routine care. Additionally, they will receive a one-time exercise counseling session delivered by a physiotherapist and an informational brochure that includes recommendations for general, unsupervised home-based exercises suitable for Parkinson's patients. No structured or supervised exercise sessions will be provided.

Other: Standard Care with Exercise Counseling

Interventions

An 8-week ballet-based dance therapy program designed to improve balance, flexibility, peripheral muscle strength, cognitive functions, and overall functional capacity in Parkinson's disease patients. The therapy will be conducted twice a week, with each session lasting approximately 60 minutes. The exercises will be adapted to the participants' physical abilities and will focus on enhancing motor coordination, strength, and stability through ballet-inspired movements.

Ballet-Based Dance Therapy

Participants in the control group will receive standard care for Parkinson's disease, including pharmacological management and routine clinical follow-up. Additionally, they will receive a one-time exercise counseling session and an informational brochure outlining general home-based exercises appropriate for individuals with Parkinson's disease. No supervised or structured exercise sessions will be conducted.

Standard Care with Exercise Counseling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older.
  • Diagnosed with Parkinson's disease.
  • Modified Hoehn and Yahr stages I to III.
  • Willingness to participate and provide informed consent.

You may not qualify if:

  • Joint deformities or severe movement limitations that prevent participation in dance exercises.
  • Mental retardation (severe cognitive impairment).
  • Major surgery within the past 6 months.
  • Presence of uncontrolled cardiovascular, pulmonary, or oncological diseases.
  • Diagnosed visual or auditory impairments affecting balance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Podlewska AM, Batzu L, Soukup T, Sevdalis N, Bakolis I, Derbyshire-Fox F, Hartley A, Healey A, Woods A, Crane N, Pariante C, Ray Chaudhuri K. The PD-Ballet study: study protocol for a randomised controlled single-blind hybrid type 2 clinical trial evaluating the effects of ballet dancing on motor and non-motor symptoms in Parkinson's disease. BMC Complement Med Ther. 2024 Jan 17;24(1):41. doi: 10.1186/s12906-023-04296-y.

    PMID: 38233784BACKGROUND
  • McGill A, Houston S, Lee RYW. Effects of a ballet-based dance intervention on gait variability and balance confidence of people with Parkinson's. Arts Health. 2019 Jun;11(2):133-146. doi: 10.1080/17533015.2018.1443947. Epub 2018 Mar 6.

    PMID: 31038440BACKGROUND

MeSH Terms

Conditions

Respiratory Aspiration

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Doç. Dr. Semiramis Özyılmaz

CONTACT

Selva Otsay

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 4, 2025

First Posted

May 23, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share